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Introduction
Centrosomes constitute two symmetrical barrel-shaped cen-
trioles that are embedded in the pericentriolar material. The 
centrioles are 200 nm in diameter and 500 nm in length 
(Doxsey, 2001; Doxsey et al., 2005; Bornens and Azimzadeh, 
2007; Lüders and Stearns, 2007; Loncarek and Khodjakov, 
2009; Nigg and Raff, 2009). The centriole barrel contains 
nine sets of microtubule triplets composed of heterodimers of   
/-tubulin in humans (Bornens, 2002; Bornens and Azimzadeh, 
2007; Nigg, 2007).
Centriole duplication is tightly coupled to the cell cycle 
(Hinchcliffe et al., 1999; Lacey et al., 1999; Meraldi et al., 1999; 
Hinchcliffe and Sluder, 2001; Tsou and Stearns, 2006b; Strnad 
and Gönczy, 2008). Once the cell enters the S phase, centriole 
duplication begins with two procentrioles emerging from the 
proximal end of the existing centrioles. The centrosome in this 
phase has a mature mother centriole with appendages that was 
assembled two cell divisions prior, an immature mother without 
appendages that was daughter in the previous cycle, and two new 
emerging procentrioles. During mitosis, each centriole pair 
moves to either end of the cell to form the spindle poles (Lange 
and Gull, 1995; Gromley et al., 2003; Anderson and Stearns, 2009). 
After mitosis and before reentry into G1, the two centrioles 
disengage in response to activation of the enzyme separase 
(Tsou and Stearns, 2006a,b). Complete maturation of daughter 
centriole to mother centriole requires passage through the 
second mitotic cycle, during which it acquires appendages 
(Robbins and Gonatas, 1964; Robbins et al., 1968; Kuriyama 
and Borisy, 1981; Vorobjev and Chentsov, 1982; Lange and 
Gull, 1995; Anderson and Stearns, 2009). Uncoupling of the 
centrosome duplication process from the cell cycle can result 
in cells with more than two centrosomes, leading to aberrant 
centrosome amplification, genetic instability, and tumor progres-
sion (Pihan et al., 1998; Doxsey, 2001; Hinchcliffe and Sluder, 
2001; Pihan et al., 2003).
The  pathway  for  centriole  biogenesis  has  been  best   
delineated  using  Caenorhabditis  elegans  (Delattre  et  al., 
2006; Pelletier et al., 2006; Dammermann et al., 2008). In   
C. elegans, a central tube is formed first, followed by assem-
bly of nine singlet microtubules on the central tube (O’Connell 
et al., 2001; Kirkham et al., 2003; Leidel and Gönczy, 2003; 
Kemp et al., 2004; Pelletier et al., 2004; Rodrigues-Martins   
et al., 2007; Dammermann et al., 2008; Kitagawa et al., 2009). 
C
entrobin is a daughter centriole protein that is es-
sential for centrosome duplication. However, the 
molecular mechanism by which centrobin func-
tions during centriole duplication remains undefined. In 
this study, we show that centrobin interacts with tubulin 
directly, and centrobin–tubulin interaction is pivotal for 
the function of centrobin during centriole duplication. We 
found that centrobin is recruited to the centriole biogenesis 
site via its interaction with tubulins during the early stage 
of centriole biogenesis, and its recruitment is dependent 
on hSAS-6 but not centrosomal P4.1–associated protein 
(CPAP) and CP110. The function of centrobin is also re-
quired for the elongation of centrioles, which is likely 
mediated by its interaction with tubulin. Furthermore, 
disruption of centrobin–tubulin interaction led to destabiliza-
tion of existing centrioles and the preformed procentriole-
like structures induced by CPAP expression, indicating 
that centrobin–tubulin interaction is critical for the stability 
of centrioles. Together, our study demonstrates that cen-
trobin facilitates the elongation and stability of centrioles 
via its interaction with tubulins.
Centrobin–tubulin interaction is required for 
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after elongation when the centrioles acquire appendage pro-
teins such as Ninein and Odf-2 (Ou et al., 2002; Ishikawa   
et al., 2005).
Our group previously identified the coiled-coil protein 
centrobin and demonstrated that it preferentially localizes to 
the daughter centriole and is required for centriole duplica-
tion (Zou et al., 2005). Centrobin is recruited to the procentri-
oles at the beginning of S phase. During S, G2, and M phases, 
there are two centrobin-positive centrioles, the newly assem-
bled procentrioles. After cell division, most G1 phase cells 
have one centrobin-positive centriole, the daughter centriole 
assembled in the previous cell cycle. Upon reentering S phase, 
centrobin on the daughter centriole assembled in the previous 
cycle becomes undetectable in the majority of the cells. In the 
absence of centrobin, no discernible centriole structures were 
assembled as demonstrated by EM analysis (Zou et al., 2005). 
Centrobin has also been reported to be a substrate of the ki-
nase Nek2 and plays a role in stabilizing the microtubule net-
work (Jeong et al., 2007). In addition, centrobin was found to 
regulate the assembly of functional mitotic spindles (Jeffery 
et al., 2010).
In this study, we elucidate the molecular mechanism of 
centrobin function during centriole duplication. We found that 
centrobin is recruited to centrosomes early during centriole du-
plication, interacts with /-tubulin dimers, and promotes the 
elongation and stability of centrioles.
In mammalian cells, the composition of centrosomes is much 
more complex (Andersen et al., 2003). The homologues of a 
small number of mammalian centrosomal proteins have been 
identified in lower eukaryotes; i.e., hSAS-6 as the homologue 
of C. elegans SAS-6 (Leidel and Gönczy, 2003; Leidel et al., 
2005), centrosomal P4.1–associated protein (CPAP)/hSAS-4 
of SAS-4 (Hung et al., 2000), CEP192 of SPD-2 (Andersen   
et al., 2003), and PLK4 of ZYG-1 (Bettencourt-Dias et al., 
2005; Habedanck et al., 2005). The homologue for SAS-5 has 
not yet been identified.
The centriole duplication process can be classified into 
initiation, elongation, and maturation (Azimzadeh and Bornens, 
2007). In humans, the initiation of procentriole biogenesis 
happens upon activation of PLK4, followed by recruitment of 
hSAS-6 to the proximal end of the existing centriole (Strnad 
et al., 2007). Although PLK4 and hSAS-6 can be recruited   
to the biogenesis site in the absence of CPAP, CEP135, and 
-tubulin, the biogenesis process does not progress beyond 
initiation. CP110 functions as a capping protein at the distal 
end of the procentriole, below which tubulin dimers are added 
to elongate the centriole wall (Kleylein-Sohn et al., 2007). 
Overexpression  of  CPAP  and  down-modulation  of  CP110   
expression result in uncontrolled elongation of centrioles, 
highlighting  the  role  of  these  proteins  in  controlling  the 
length of centrioles (Kohlmaier et al., 2009; Schmidt et al., 
2009; Tang et al., 2009). Maturation of the centrioles occurs   
Figure 1.  Centrobin is recruited to the centri-
ole biogenesis site after hSAS-6. (A [first and 
second  panels]  and  B)  hSAS-6  recruitment 
to the centriole biogenesis site is not depen-
dent on the presence of centrobin. HeLa cells 
transfected  with  control  or  centrobin  siRNA 
were treated with HU and stained with anti-
centrobin, hSAS-6, and -tubulin antibodies. 
The percentage of hSAS-6–positive centrioles 
is shown in B. (A [first and third panels] and C) 
Centrobin recruitment to the centriole biogene-
sis site is dependent on the presence of hSAS-6.   
HeLa  cells  treated  with  control  or  hSAS-6 
siRNAs and HU were stained as previously de-
scribed for A, first and second panels, and the 
percentage of cells with centrobin-positive cen-
trioles is plotted in C. Histograms are plotted as 
mean ± SEM (n = 3). The asterisk denotes that 
the difference is significant, and P < 0.001.   
Bars, 1 µm.713 Centrobin–tubulin binding in centriole duplication • Gudi et al.
staining dots (50% and 45%, respectively), indicating that cen-
trobin has been recruited and centriole biogenesis is in progress. 
However, 90% of hSAS-6–depleted cells had either one or zero 
centrobin dots (Fig. 1, A [first and third panels] and C). Therefore, 
it can be concluded that centrobin recruitment to the daughter cen-
trioles depends on prior hSAS-6 recruitment, whereas the recruit-
ment of hSAS-6 is not dependent on the presence of centrobin.
Centrobin recruitment to the centriole 
biogenesis site is not dependent on the 
recruitment of CPAP and CP110
In addition to PLK4 and hSAS-6, CPAP and CP110 have also 
been demonstrated to be recruited to the centriole biogenesis 
site at a very early stage, and CPAP is also required for procen-
triole biogenesis (Kleylein-Sohn et al., 2007). Recruitment of 
hSAS-6 to the procentriole initiation site was not affected in the 
absence of CPAP and CP110 proteins (Kleylein-Sohn et al., 
2007; Kohlmaier et al., 2009). To further delineate the order of 
centrobin recruitment during the centriole biogenesis process, 
we examined centrobin recruitment in the CPAP and CP110 
RNAi cells. We found that centrobin was still recruited to the 
centriole biogenesis site in the CPAP- and CP110-depleted cells 
(Fig. 2, A and B and C and D, respectively), suggesting that 
centrobin recruitment is not dependent on the prior recruitment 
of CPAP and CP110. Knockdown efficacy of CPAP RNAi was 
assessed in parallel by its effect on centriole duplication using 
acetylated tubulin as a centriole marker. Although >90% of the 
control cells exhibited four centrioles, <30% of CPAP-depleted 
cells had four centrioles (Fig. S1, A and B), indicating that 
Results
Centrobin is recruited to the centriole 
biogenesis sites after hSAS-6
Recent studies have identified hSAS-6 as the critical protein to ini-
tiate centriole biogenesis. Upon PLK4 activation, hSAS-6 is re-
cruited to the proximal end of the existing centrioles (Habedanck   
et al., 2005; Kleylein-Sohn et al., 2007; Strnad et al., 2007). Here, 
we first examined whether centrobin is recruited to the site of cen-
triole biogenesis before or after hSAS-6. For this purpose, we de-
pleted centrobin in HeLa cells using siRNA and treated the cells 
with hydroxyurea (HU) for 16 h. Similar to control cells, >90% of 
the centrobin-depleted cells still had two hSAS-6 dots, indicating 
that hSAS-6 can be recruited to the centriole biogenesis site in the 
absence of centrobin (Fig. 1, A [first and second panels] and B).
Next, recruitment of centrobin to the centrioles was assessed 
in HU-treated HeLa cells transfected with control and hSAS-6 
siRNAs by centrobin staining. It should be noted that HU treat-
ment inhibited the decrease of centrobin from the daughter 
centriole (Fig. 1, A and C, control cell). Therefore, in these ex-
periments, cells with two or three centrobin staining dots are the 
cells that have already recruited centrobin to the centriole bio-
genesis sites and are in the process of assembling the procentri-
ole as opposed to untreated cells that have only one centrobin 
staining dot at G1 phase and two centrobin staining dots at S phase 
(see Fig. 8 L; Zou et al., 2005). The molecular mechanism of 
displacement/degradation of centrobin from the daughter centriole 
is currently under investigation in our laboratory. As shown   
in Fig. 1 C, the control cells had either three or two centrobin 
Figure 2.  Centrobin recruitment to the centriole biogenesis site is not dependent on CPAP and CP110. (A, B, C [first and second panels], and D) Centrobin 
recruitment to the centriole biogenesis site is not inhibited by CPAP and CP110 knockdown. HeLa cells transfected with control, CPAP, or CP110 siRNAs were 
treated with HU and stained using anti-centrobin, -tubulin, CPAP, or CP110 antibodies. The percentage of centrobin-positive centrioles is shown in B and D.   
(C [first and third panels] and E) Knockdown of centrobin inhibits recruitment of CP110. HeLa cells transfected with control or centrobin siRNA and HU were 
stained using -tubulin, centrobin, and CP110 antibodies. The percentage of CP110-positive centrioles is shown in E. Histograms are plotted as mean ± 
SEM (n = 3). The asterisk denotes that the difference is significant, and P < 0.001. Bars, 1 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   714
induced to express CPAP for 24, 48, and 96 h by addition of 
doxycycline and then were stained with anticentrobin and antiacety-
lated tubulin antibodies to visualize the elongated procentriole-
like structures (PLSs). As reported previously (Tang et al., 2009), 
we observed that at 24 h after induction (Fig. 3 C, second panel), 
mainly the daughter centriole started to elongate, and centrobin 
was present along the elongating centriole. At later time points 
(Fig. 3 C, second and third panels), both mother and daughter cen-
trioles were elongated. Centrobin staining was found not only on 
the daughter centrioles but also on the elongated portion of mother 
centrioles, whereas the original portion of mother centrioles was 
devoid of centrobin staining (Fig. 3, C [bottom row] and D). The 
identity of the elongated mother centriole was confirmed by 
costaining with anti–C-NAP1 antibody together with anticentro-
bin and -tubulin antibodies (Fig. 3 D; Fry et al., 1998). The 
presence of centrobin on the elongated portion of the mother also 
indicates a role of centrobin during centriole elongation.
Furthermore, we depleted centrobin in the U2OS-CPAP 
cells using siRNA before inducing CPAP expression. As ex-
pected, 60% of the control cells exhibited elongated PLSs 
(Fig. 3, E [left panel, bottom row] and F). In comparison, only 
20% of the centrobin-depleted cells had the elongated PLS in 
spite of the induction of CPAP expression for 72 h (Fig. 3 F). In 
summary, these findings demonstrate a critical role of centrobin 
in the centriole elongation process.
Centrobin interacts with tubulin in vivo
Because our finding proved a critical role of centrobin during the 
centriole elongation process, we next explored the mechanism by 
which centrobin functions during centriole elongation. The centri-
olar wall is composed of nine sets of microtubule triplets assembled 
from heterodimers of - and -tubulin, and centriole elongation is 
a process of adding tubulin dimers to the initiation structure under-
neath the CP110 cap (Kleylein-Sohn et al., 2007). Therefore, we 
examined whether centrobin interacts with tubulins. Centrobin   
interaction with tubulin was first examined by exogenously ex-
pressing GFP-centrobin in 293T cells and subjecting the lysates   
to immunoprecipitation using anti–-tubulin antibody. Immuno-
blotting analysis revealed that a significant fraction of the over-
expressed centrobin can be pulled down using anti–-tubulin 
antibody, clearly indicating an interaction of centrobin and   
-tubulin (Fig. 4). We further performed coimmunoprecipita-
tion of endogenous centrobin and -tubulin in lysates of 293T 
cells (Fig. S2). Indeed, we observed that anticentrobin but 
not the isotype control antibody could pull down -tubulin 
(Fig. S2 A). The corollary stands true that anti–-tubulin antibody 
can also immunoprecipitate endogenous centrobin (Fig. S2 B), 
indicating that centrobin interacts with -tubulin in vivo. This 
interaction is likely important for the function of centrobin 
during centriole duplication.
Centrobin binds to tubulin in vitro, and 
its C terminus (aa 765–903) contains 
the tubulin-binding domain as well as 
centrosome localization ability
To identify the tubulin binding region of centrobin, an in vitro 
tubulin dimer binding assay was performed. A low concentration 
CPAP was efficiently depleted, thereby resulting in a block in 
centriole duplication. Our data indicate that centrobin recruit-
ment is not dependent on CPAP, but its recruitment is not suffi-
cient for centrobin duplication to progress in the absence of 
CPAP as expected. CP110 RNAi efficiency was evaluated by 
quantitating the percentage of cells having elongated centrioles. 
40% of the CP110 RNAi cells had elongated centrioles, sug-
gesting that CP110 has also been depleted effectively (Fig. S1, 
C and D). However, we cannot completely rule out the possibil-
ity that the residual amount of CPAP and CP110 present might 
be sufficient for centrobin recruitment to the centrioles.
We further examined CP110 recruitment to procentrioles 
in centrobin RNAi cells. We found that only 30% of the cen-
trobin RNAi–transfected cells exhibited four CP110 staining dots, 
whereas 90% of the control cells exhibited four CP110 staining 
dots (Fig. 2, C [first and third panels] and E), suggesting that 
CP110 recruitment requires prior recruitment of centrobin. A simi-
lar experiment was attempted to examine the recruitment of CPAP 
in the absence of centrobin. However, because CPAP is localized 
to the proximal end of the parental centrioles (Kleylein-Sohn   
et al., 2007; Kohlmaier et al., 2009; Schmidt et al., 2009), it was im-
possible to unambiguously distinguish the newly recruited CPAP   
protein from the CPAP existing on the parental centrioles by   
immunofluorescence. We indeed observed small CPAP staining 
dots as reported in the hSAS-6–depleted cells (Kohlmaier et al., 
2009), but it could just be a consequence of inhibited centriole   
elongation. Hence, we were unable to determine whether the recruit-
ment of CPAP is dependent on the presence of centrobin. Because 
both CPAP and CP110 are members of the early initiation proteins 
along with CEP135 and -tubulin (Kleylein-Sohn et al., 2007),   
our studies indicate that centrobin is also one of the early initiation 
proteins because it was recruited to the centriole biogenesis site 
before CPAP/CP110 and is required for the CP110 recruitment.
Centrobin is required for the elongation 
of centrioles in normal and CPAP-
overexpressing cells
To determine whether centrobin is required only for assembly of 
the initiation structure or also for further elongation of the cen-
triole, we examined the size of newly assembled daughter centri-
oles by staining one of the core centriole components, -tubulin 
in HU-treated centrobin-depleted HeLa cells. Although nearly all 
of the control cells had four centrioles, 20% of centrobin-depleted 
cells exhibited only two centrioles, indicating that centrobin de-
pletion inhibited centriole duplication. Detailed analysis of the 
centrobin-depleted cells still having four -tubulin–stained cen-
trioles revealed that in 58% of these cells, two of the four centri-
oles stained much weaker for -tubulin, indicating that daughter 
centriole elongation is likely stunted in these centrobin-depleted 
cells (Fig. 3, A and B). This finding suggests that centrobin likely 
also functions during centriole elongation.
Recently, it was reported that centrioles can elongate be-
yond the predetermined length of 500 nm upon CPAP over-
expression or CP110 depletion (Kohlmaier et al., 2009; Tang   
et al., 2009). This system enables us to study the role of centrobin 
in centriole elongation specifically. The U2OS cells inducibly 
expressing CPAP reported by Kohlmaier et al. (2009) were 715 Centrobin–tubulin binding in centriole duplication • Gudi et al.
Figure 3.  Centrobin is required for the elongation of centrioles. (A and B) Centrobin is required for centriole elongation during normal centriole duplica-
tion. HeLa cells transfected with control or centrobin siRNA were treated with HU and stained with anti-centrobin, hSAS-6, and -tubulin antibodies. The 
percentage of varied intensity of -tubulin–positive centrioles was scored and plotted in B. (C and D) Centrobin was observed on the elongated portion of 
the mother centriole in addition to the elongating daughter centrioles. CPAP-induced PLSs were generated by inducing U2OS-CPAP cells with 1 µg/ml doxy-
cycline for the indicated time points. Anti-centrobin and acetylated tubulin antibodies were used to stain centrioles/PLSs (C). In D, the cells were costained 
with anti–C-NAP1, centrobin, and -tubulin antibodies. The illustration indicates the presence of centrobin on the elongated portion of the mother centriole 
as well. M and D refer to the mother and daughter centriole, respectively. (E and F) Knockdown of centrobin inhibits the elongation of PLSs. U2OS-CPAP 
cells were transfected with control or centrobin siRNAs for 72 h followed by doxycycline treatment for the indicated time points (E). The percentage of 
elongated versus nonelongated centrioles was quantified at the 72-h time point (F). Histograms are plotted as mean ± SEM (n = 3). Asterisks denote that 
the difference is significant, and P < 0.001. Bars, 1 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   716
of a constant amount of full-length centrobin significantly hin-
dered the binding of full-length centrobin to tubulin (Fig. 6 A, 
fifth and sixth lanes), indicating that the interaction of full-
length centrobin with -tubulin is disrupted in the presence of 
centrobin-TuBD.
To rule out the possibility that centrobin-TuBD may 
form a nonfunctional unit by dimerizing with the full-length 
centrobin, we coexpressed either myc-centrobin or GFP-myc– 
centrobin-TuBD along with GFP-centrobin in 293T cells to 
test the dimerization potential of centrobin and its mutants. 
Immunoprecipitation using the anti-myc antibody revealed that 
full-length myc-centrobin bound strongly to full-length GFP-
centrobin (Fig. 6 B, first panel, third lane), but centrobin-TuBD 
did not (Fig. 6 B, first panel, first and second lanes), suggesting 
that though centrobin has the potential to dimerize/polymerize 
with itself, its C-terminal 139 residues are not responsible for 
this ability. Together, these findings prove that centrobin-TuBD   
is capable of disrupting the endogenous centrobin–tubulin inter-
action (Fig. 6) and can serve as a valuable tool to dissect the func-
tion of this interaction during the centriole duplication process.
Disruption of the interaction of centrobin 
and centrosomal tubulin by centrobin-TuBD 
inhibits centrobin recruitment  
to the centriole biogenesis site and 
centriole elongation
Because centrobin-TuBD can disrupt the centrobin–tubulin   
interaction, we examined whether centrobin-TuBD affected the 
recruitment of endogenous centrobin to the centrioles. For 
this purpose, HeLa cells were transfected with either GFP or 
GFP–centrobin-TuBD, treated with HU, and then immuno-
stained using anticentrobin antibody (Fig. 7 G). Our anticentrobin 
antibody recognizes an epitope that is outside of the centrobin-
TuBD region, and therefore, it can only stain the endogenous 
centrobin. As shown in Fig. 7 (A and B), although most of the 
control cells had either two or three centrobin-positive centri-
oles, 28% of centrobin-TuBD–expressing cells had less than 
two centrobin-positive centrioles (Fig. 7, A and B), suggest-
ing that centrobin recruitment to the centrioles is affected in 
centrobin-TuBD–expressing cells. Observation of a significantly 
larger percentage of centrobin-TuBD–expressing cells with 
-tubulin–positive centrioles but no centrobin (Fig. 7 A, sec-
ond  panel)  suggests  that  the  interaction  of  centrobin  and   
centrosomal tubulins is responsible for recruitment of endog-
enous centrobin to the centriole and that centrobin-TuBD dis-
rupts this interaction.
Centrin staining has been found to be a good marker for 
centriole duplication (Middendorp et al., 2000; Salisbury et al., 
2002; Strnad et al., 2007; Azimzadeh et al., 2009). Therefore, 
we stained the aforementioned centrobin-TuBD–expressing   
cells with anti–centrin 3 antibody. As shown in Fig. 7 (C and D), 
although 97% of the control cells had four centrioles per cell, 
only 40% of the centrobin-TuBD–transfected cells had four 
centrin-positive centrioles per cell. Similarly, when the cells 
were  stained  for  CP110,  only  32%  of  the  centrobin-TuBD–
transfected cells had four CP110-positive centrioles, whereas   
94% of the control cells had four CP110-positive centrioles 
(1 µg/ml) of /-tubulin purified from HeLa cells was incu-
bated with GST, GST-centrobin, or its mutants at 4°C. Under 
this condition, tubulin exists as dimers and does not polymerize 
into microtubules. As shown in Fig. 5 A, full-length centrobin 
bound to HeLa tubulins. In comparison, centrobin mutant 365–
903 but not 1–364 bound to tubulins, suggesting that the tubulin-
binding domain on centrobin maps to its C-terminal aa 365–903 
(Fig. 5 A). A systematic mutagenesis of this region was then 
performed to precisely map the tubulin-binding domain on cen-
trobin (Fig. 5, B, D, and E). We found that the binding site for 
tubulin on centrobin localizes to its C-terminal 139 residues (aa 
765–903, referred to as centrobin-TuBD in the rest of the manu-
script; Fig. 5, B and E).
Jeong et al. (2007) reported that the centrosome localiza-
tion domain of centrobin is within aa 723–903. Our study indi-
cates that the tubulin binding region of centrobin is restricted   
to aa 765–903 in its C terminus. In immunofluorescence experi-
ments, we observed a diffuse cytoplasmic and strong nuclear 
localization for centrobin-TuBD. In addition, centrobin-TuBD 
also exhibited a clear centrosomal localization, as is evident by 
its colocalization with centrin staining (Fig. 5 F, panel a), sug-
gesting that the tubulin-binding domain of centrobin is sufficient 
for its centrosomal localization. The nuclear localization of   
centrobin-TuBD is likely a result of the presence of an NLS in this 
fragment of centrobin. No microtubule localization of centrobin-
TuBD was observed (Fig. 5 F, panel b). Furthermore, expression of 
centrobin-TuBD did not grossly affect the centrosome-mediated 
microtubule nucleation (Fig. 5 G).
Overexpression of centrobin-TuBD can 
disrupt the interaction of endogenous  
full-length centrobin with tubulin
To test whether centrobin-TuBD expression can dominant nega-
tively disrupt the endogenous centrobin–tubulin interaction, we 
cotransfected 293T cells with GFP-centrobin either alone or to-
gether with increasing amounts of centrobin-TuBD. Cells were 
then subjected to immunoprecipitation using anti–-tubulin anti-
body followed by immunoblotting for centrobin. Though both 
full-length and centrobin-TuBD bound very well to -tubulin 
when expressed by themselves (Fig. 6 A, second and third 
lanes), increased expression of centrobin-TuBD in the presence 
Figure  4.  Centrobin interacts with -tubulin in vivo.  293T  cells  trans-
fected with control or GFP-centrobin vectors were lysed and subjected to 
immunoprecipitation (IP) using anti–-tubulin antibody. Immunoblotting (IB) 
was performed with anti-GFP and anti–-tubulin antibodies for detection of 
GFP-centrobin and endogenous -tubulin, respectively. Molecular mass is 
indicated in kilodaltons.717 Centrobin–tubulin binding in centriole duplication • Gudi et al.
Figure 5.  Centrosome localization ability and the tubulin-binding domain of centrobin map to its C terminus (aa 765–903). (A–D) Centrobin interacts with 
tubulin in vitro, and the tubulin-binding domain maps to aa 365–903. GST or GST-centrobin and its mutants were incubated with HeLa cell tubulin at 4°C.   
The bound proteins were fractionated and immunoblotted with anti–-tubulin antibody. Input, an aliquot of 10% tubulin used in the binding reactions.   
The input of purified GST or GST-centrobin and its mutant proteins (C and D) were stained by Coomassie blue. Molecular mass is indicated in kilodaltons. 
(E) A schematic representation of centrobin and its mutants summarizing their binding with -tubulin. (F) Centrobin 765–903 localizes to centrosomes but not the 
microtubules. HeLa cells transfected with GFP-centrobin 765–903 were stained with anti–centrin 3 and anti–-tubulin antibodies to visualize the centrioles 
(panel a) and microtubules (panel b), respectively. (G) GFP–centrobin 765–903 or centrobin-TuBD does not inhibit the microtubule nucleation process. HeLa 
cells transfected with control or centrobin-TuBD vectors were subjected to aster formation assay and stained with anti–-tubulin. Quantification of different 
sizes of asters is presented. Histograms are plotted as mean ± SEM (n = 3). Bars, 1 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   718
(Fig. 7, E and F). These findings indicated that centriole elon-
gation was blocked in the centrobin-TuBD–expressing cells 
(Fig. 8 L, panel a).
Expression of centrobin-TuBD leads  
to centriole destabilization
Surprisingly, we also noticed that 15% of the centrobin-TuBD–
expressing cells (Fig. 7, D and F) exhibited no centrin- or 
CP110-staining centrioles, which is different from what we 
observed in centrobin depletion experiments in which cells with-
out centrin-staining centrioles were rarely observed (Zou et al., 
2005). We think that three explanations are possible: first, as a 
result of two rounds of cell division without centriole duplica-
tion, centrobin-TuBD likely has a more potent inhibitory effect 
on centriole duplication but has a less potent effect on cell 
division than centrobin RNAi because it likely does not inter-
fere with the other potential functions of centrobin. Second, 
centrobin-TuBD displaced the centrin and CP110 proteins from 
the existing centriole. Third, centrobin-TuBD can destabilize 
the existing centrioles.
To  distinguish  among  these  possibilities,  HeLa  cells 
were first synchronized in S phase by HU treatment for 8 h   
before transfection with centrobin-TuBD (Fig. 8 I). Anti–centrin 3   
staining was performed 72 h after transfection. As shown in 
Fig. 8 (A and B), 20% of the centrobin-TuBD–transfected HeLa 
cells still exhibited zero centrioles. This finding was further 
confirmed in presynchronized U2OS cells (Fig. 8, C and D) in 
which the centrosome duplication process is uncoupled from 
the cell cycle but the centriole duplication proceeds unhampered 
(Stucke et al., 2002). As expected, 70% of the control cells 
had eight or more centrioles per cell. However, in the centrobin-
TuBD–transfected U2OS cells, only 20% of the cells had eight 
or more centrioles per cell, indicating that centriole elongation 
is blocked in these cells as well. Again, we found that 20% of the 
centrobin-TuBD–transfected cells had zero centrioles (Fig. 8 D).   
Because the cells had been arrested in S phase for 8 h before 
and after transfection, no cell division was possible; therefore, 
the presence of cells with zero centrioles is not a result of two 
rounds of cell division without centriole duplication. Addition-
ally, these data also confirm that the centrobin-TuBD–mediated 
effect was not a result of the effect of centrobin-TuBD on the 
cell cycle but rather a result of its direct effect on centrioles.
Both centrin and CP110 are proteins that localize to the 
distal portions of the centriole. To distinguish between dis-
placement of these two proteins from the existing centrioles 
or the destabilization of the entire centriole, HeLa cells pre-
treated with HU and transfected with the centrobin-TuBD as 
described in this section were costained with anti–-tubulin 
and CP110 antibodies. Z stack images were obtained to exam-
ine the presence of anti–-tubulin– and anti-CP110–stained 
Figure 6.  Centrobin-TuBD disrupts the inter-
action  of  full-length  centrobin  with  tubulin.  
(A) Overexpression of centrobin-TuBD disrupts 
the interaction of endogenous full-length cen-
trobin  with  -tubulin.  293T  cells  transfected 
with vector, GFP-centrobin or GFP–centrobin-
TuBD,  or  in  combination  as  indicated  were 
lysed  and  subjected  to  immunoprecipitation 
(IP)  with  anti–-tubulin  antibody.  The  bound 
proteins  were  fractionated  and  detected  by 
immunoblotting  (IB)  using  the  indicated  anti-
bodies. (B) Centrobin-TuBD does not have the 
potential  to  dimerize/polymerize  with  full-
length centrobin. 293T cells transfected with 
vector, myc-centrobin, or GFP-myc–centrobin-
TuBD  along  with  GFP-centrobin–expressing 
constructs were lysed and subjected to immuno-
precipitation using anti-myc antibody. Immuno-
blotting  was  performed  with  anti-GFP  and   
anti-myc antibodies. Molecular mass is indi-
cated in kilodaltons.719 Centrobin–tubulin binding in centriole duplication • Gudi et al.
To confirm the specificity of the observed effect of cen-
trobin-TuBD,  we  tested  whether  coexpression  of  full-length 
centrobin can rescue the centrobin-TuBD–mediated centriole 
destabilization and inhibition of centrobin recruitment and cen-
triole elongation. We found that upon high coexpression of full-
length centrobin, the effect of centrobin-TuBD on centrobin 
recruitment, centriole elongation, and centriole stability was sig-
nificantly reduced (Fig. 8, G and H). This partial but significant 
centrioles (Fig. 8, E and F). Our analysis revealed that in 24% 
of these cells, no visibly discernible centrioles were present 
(Fig. 8 F). It is noticeable that the cells lacking centrioles were 
not necessarily expressing the highest level of centrobin-TuBD 
(not depicted). Because -tubulin forms the core structure of the 
centriole, this finding indicated that expression of centrobin-TuBD 
was able to destabilize the existing centrioles in addition to in-
hibiting the daughter centriole formation (Fig. 8 L, panel a).
Figure 7.  Disruption of centrobin–tubulin interaction inhibits centrobin recruitment to the centriole biogenesis site and centriole elongation. (A and B) Centrobin-
TuBD overexpression blocks centrobin recruitment to the centrioles.HeLa cells transfected with control or GFP–centrobin-TuBD vectors and treated with HU 
were stained with anti-centrobin and anti-tubulin antibodies. The percentage of cells with indicated numbers of centrobin-positive centrioles is shown in B. 
(C–F) Centrobin-TuBD overexpression inhibits centriole duplication and elongation. Experiments were performed as depicted in the schematic (G), except 
that the cells were stained with anti–centrin 3 (C and D) and CP110 (E and F) antibodies. D and F represent the percentage of cells with the indicated 
number of centrin 3– and CP110-positive centrioles, respectively. Histograms are plotted as mean ± SEM (n = 3). Asterisks denote that the difference is 
significant, and P < 0.001. Bars, 1 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   720
Figure 8.  Disruption of centrobin–tubulin interaction destabilizes the centrioles. (A–I) Centrobin–tubulin interaction confers stability to the centrioles. HeLa 
(A, B, E, and F) and U2OS (C and D) cells pretreated with HU and transfected with either control or GFP–centrobin-TuBD were stained with anti–centrin 3   
(A–D) or anti–-tubulin and CP110 antibodies (E and F), and the percentage of cells with the indicated number of respectively stained centrioles is 
presented. (G and H) Increasing concentration of full-length centrobin partially rescued the inhibitory effect of centrobin-TuBD on centrobin recruitment 
and centriole elongation. HU-pretreated HeLa cells were transfected with centrobin-TuBD, full-length centrobin (pMini-myc-centrobin), or a combination   721 Centrobin–tubulin binding in centriole duplication • Gudi et al.
as indicated. Cells were stained with anti-centrobin (G) and centrin 3 (H) antibodies, and the percentage of centrobin (G)- and centrin 3 (H)–positive 
centrioles is presented. (I) The schematic depicts the experimental method in A–H. (J) EM analysis of centrobin-TuBD cells. HeLa cells pretreated with HU 
and transfected with control or GFP–centrobin-TuBD were processed for EM, and 250-nm-thick sections were analyzed to detect centrosomes. (K) Over-
expression of centrobin-TuBD destabilizes the preformed PLSs. U2OS-CPAP cells preinduced with doxycycline for 96 h were transfected with control or 
GFP–centrobin-TuBD along with dsRed–centrin 1 vector. dsRed-centrin–positive cells were evaluated for the presence of elongated or nonelongated PLSs 
by staining with anti-acetylated tubulin antibody. (L) The schematic illustrates the destabilization effect of centrobin-TuBD in HU-treated cells (panel a) or 
U2OS-CPAP–overexpressing cells (panel b). Histograms are plotted as mean ± SEM (n = 3). Asterisks denote that the difference is significant, and P < 0.001. 
Bars: (A and C) 1 µm; (E) 3 µm; (J) 100 nm.
 
rescue by full-length centrobin suggests that the major effects 
of centrobin-TuBD on centrioles are specific, possibly through 
competition with endogenous centrobin for interaction with 
centrosomal tubulin.
To  further  confirm  that  some  of  the  centrobin-TuBD– 
expressing cells indeed lost their centrioles, electron microscopic 
analysis of centrioles on thick 250-nm sections of HU-pretreated, 
GFP, or centrobin-TuBD–transfected HeLa cells was performed 
(Fig. 8 J). Although 12 morphologically normal centrioles were 
found in 300 control HeLa cells analyzed on randomly selected 
sections, only three centrioles were found in the 500 centrobin-
TuBD–expressing cells analyzed. This finding indicated that a 
portion of the centrobin-TuBD–transfected cells indeed has no 
discernible centrioles, indicating that expression of centrobin-
TuBD is able to destabilize the existing centrioles. The centrioles 
observed in centrobin-TuBD–expressing cells did not exhibit any 
obvious defects, likely because the destabilization process is a 
rapid process or the partially destabilized centrioles were not eas-
ily recognizable under EM. In summary, these findings indicate 
that disruption of centrobin–tubulin interaction leads to centriole 
destabilization, and centrobin–tubulin interaction is required to 
maintain the stability of the centriole (Fig. 8 L, panel a).
Centrobin-TuBD destabilizes elongated 
PLSs in CPAP-expressing cells
Next, we tested whether disruption of centrobin–tubulin inter-
action can destabilize the CPAP-induced PLS. First, the U2OS-
CPAP cells were induced for 96 h to form the elongated PLS 
(Fig. 8 K, schematic), after which the cells were cotransfected with 
vector or GFP–centrobin-TuBD together with dsRed–centrin 1– 
expressing vectors to mark the transfected cells. At 72 h after   
transfection, cells were stained with antiacetylated tubulin anti-
body to quantify the percentage of cells with PLSs in the dsRed-
centrin–positive cells. The elongated PLS in these cells was 
evaluated and shown in Fig. 3. Although 67% of the control   
cells had elongated PLSs, upon transfection with centrobin-TuBD, 
the number of cells with PLSs was reduced to 33% (Fig. 8 K). 
These findings indicate that disruption of centrobin–tubulin 
binding by the centrobin-TuBD can destabilize the preformed 
elongated PLS (Fig. 8 L, panel b), further corroborating the 
aforementioned finding that the centrobin–tubulin interaction is 
important for maintaining the stability of centrioles.
Discussion
Previously, we identified centrobin as a centrosomal protein that 
is preferentially localized to the daughter centriole and is re-
quired for centriole duplication (Zou et al., 2005). In this study, 
we further elucidate the role of centrobin during centriole dupli-
cation. We found that centrobin recruitment to the procentrioles 
is dependent on the presence of hSAS-6 but not CPAP and 
CP110. The recruitment of CP110 but not hSAS-6 to the centri-
ole biogenesis site requires the presence of centrobin, suggest-
ing that centrobin is one of the important centriole initiation 
proteins. Furthermore, we found that centrobin is also required 
for centriole elongation and stability.
Centrioles are predominantly composed of /-tubulins. 
Centriole elongation, at least visually, is the process of assem-
bling the nine microtubule triplets by adding /-tubulin dimers 
to an undefined initiating template structure. Here, we demon-
strate that centrobin interacts directly with the core compo-
nents of the centriole, -tubulins via its C-terminal 139 residues 
(centrobin-TuBD). Centrobin-TuBD exhibited a clear centro-
somal localization in addition to a diffused cytoplasmic and nu-
clear localization. It is noticeable that although centrobin-TuBD 
can bind strongly to tubulins, no detectable microtubular local-
ization of centrobin-TuBD or adverse effect on microtubule 
nucleation was observed. Although surprising, this finding cor-
relates with our previous observation that endogenous centrobin 
is not clearly detectable on microtubules (Zou et al., 2005). Jeong 
et al. (2007) had reported that centrobin is detectable in associa-
tion with the roots or initiating points of microtubules in U2OS 
and MCF7 cells but not in HeLa cells. It is very likely that the 
tubulins at the initiating points of microtubules and tubulins at 
the centrosomes share similar conformation with the centro-
somal tubulins, in which their centrobin-binding domain is ex-
posed. When the tubulins are assembled into microtubules, the 
centrobin-binding domain is no longer accessible.
Importantly, overexpression of centrobin-TuBD can dis-
rupt the endogenous full-length centrobin–tubulin interaction, 
providing us with a valuable tool to dissect the function of cen-
trobin during centrobin duplication. Using centrobin-TuBD, we 
demonstrated that centrobin is recruited to centrioles and facili-
tates centriole elongation via its interaction with centrosomal 
tubulins. Moreover, we found that centrobin-TuBD overexpres-
sion destabilized the existing mother centrioles in addition to 
inhibiting the assembly of new centrioles (Fig. 8 L, panel a), in-
dicating that centrobin is required for the stability of centrioles. 
Our previous findings (Zou et al., 2005) indicated that, in asyn-
chronized cells, centrobin is mainly found on the daughter cen-
trioles. Even in HU-treated cells, in which the degradation or 
displacement of centrobin from the daughter centriole is inhib-
ited, there is at least one or two mother centrioles exhibiting no 
centrobin staining, which will suggest that centrobin should not 
be required for the stability of these mature centrioles. We propose 
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scaffold protein via its interaction with tubulins to facilitate the 
addition of tubulin dimers to the centriole initiation complex. Cen-
trobin also acts to stabilize the newly assembled daughter cen-
trioles before their maturation. Whether centrobin is required to 
maintain the stability of the mature mother centriole remains to 
be determined. The function of centrobin during centriole elon-
gation and its function to maintain the stability of the centriole 
are likely both mediated by its ability to bind to tubulins.
CPAP also has the ability to bind to microtubules (Hung   
et al., 2004), and regulation of its cellular levels is required to 
maintain the centriole length (Tang et al., 2009). It has been 
suggested that as a result of its tubulin binding property, CPAP 
might act as a scaffold for tubulin addition during procentriole 
biogenesis. Because the property of tubulin binding is shared by 
CPAP and centrobin and both are required for centriole biogen-
esis (Cho et al., 2006; Kohlmaier et al., 2009), it would be interest-
ing to study whether centrobin and CPAP cooperate to facilitate 
the assembly of the microtubule triplets that form the main 
structure of centrioles. So far, there is no convincing evidence 
indicating the existence of a lower eukaryotic centrobin homo-
logue. If centrobin indeed cooperates with CPAP for centriole 
elongation, it will indicate that centrobin is functionally similar 
to C. elegans SAS-5. In summary, we conclude that centrobin–
tubulin interaction is pivotal for centrobin recruitment to the 
centriole biogenesis site, centriole elongation, and stabilization 
of nascent centrioles until maturation.
Materials and methods
Cell lines and transfections
293T cells were cultured in DME supplemented with 10% FBS and trans-
fected  by  the  calcium  phosphate  method.  HeLa  and  U2OS  cells  were 
grown in MEM  medium containing 10% FBS and were transfected by 
calcium phosphate precipitation. U2OS cells inducibly expressing CPAP 
(a gift from P. Gönczy, Swiss Institute for Experimental Cancer Research, 
Swiss Federal Institute of Technology, Lausanne, Switzerland) were grown 
in MEM  medium containing 10% FBS and were switched to the same 
medium containing 1 µg/ml doxycycline to induce the expression of CPAP. 
siRNAs were transfected using the Oligofectamine reagent (Invitrogen).
Antibodies and reagents
Anticentrobin  polyclonal  antibody  has  been  described  previously  (Zou   
et al., 2005). Monoclonal anticentrobin antibody (clone 2E3) has been 
generated using the monoclonal antibody core facility at Northwestern 
University, purified, and characterized in our laboratory. Using centrobin 
knockdown cells, we conclusively demonstrated that this monoclonal anti-
centrobin antibody can recognize centrobin specifically in Western blot-
ting and immunofluorescence (Fig. 2 C). Anti–-tubulin antibodies (clone 
DM1A for Western blotting and immunofluorescence and clone B-5-1-2 for 
First, centrobin is indeed required for the stability of both 
daughter and mature mother centrioles. On the mature mother 
centrioles, centrobin is still there to maintain their stability but 
becomes undetectable because additional mother centriole pro-
teins block the access of centrobin antibody. Second, centrobin 
is only required to maintain the stability of the daughter centri-
oles. Once the daughter centrioles mature to become mother 
centrioles by recruiting additional mother centriole proteins and 
extensive modification of centriolar tubulins, centrobin is no 
longer required for their stability. Centrobin is then either degraded 
or displaced from the mother centrioles by the mother centriole 
proteins or the tubulin modifications. However, because of the 
small size of centrobin-TuBD and its presence at high concen-
tration, it can still access the centrobin-binding domain on the 
tubulins and competes with the mother centriole proteins. Con-
sequently, centrobin-TuBD will displace the mother centriole 
proteins and lead to destabilization of the mother centrioles.   
Although our current data cannot distinguish between these two 
scenarios, we speculate that the first scenario is more plausible 
because centrobin can indeed be present on the mother centriole 
as is evident in HU-treated cells. One seemingly conflicting 
piece of evidence against this hypothesis is that centrobin deple-
tion inhibited the centriole duplication but did not destabilize 
the mother centrioles. The likely explanation is that centrobin 
assembled into the mother centrioles is stabilized and is impervi-
ous to depletion, as are most cellular structural proteins. Hence, 
centrobin depletion cannot destabilize the mother centriole, 
whereas centrobin-TuBD can displace the centrobin on the 
mother centrioles and lead to their destabilization. However, we 
do not have direct evidence for this, and further studies are re-
quired to prove this scenario. Furthermore, in our rescue experi-
ments, the existing centrioles were still destabilized in 5% of 
cells and were not rescued by the wild-type centrobin expres-
sion; therefore, it is possible that both scenarios can coexist and 
account for the observed destabilization of existing centrioles.
The key findings from this study suggest that centrobin 
functions at least at three stages of the centriole duplication 
pathway as depicted in Fig. 9. At the beginning of centriole 
biogenesis, hSAS-6 is first recruited to the proximal end of the 
mother centrioles in the G1/S phase. Centrobin is then recruited 
and likely participates in the undefined centriole initiation struc-
ture formation along with the other proposed centriole initiation 
proteins, including CPAP, CEP135, -tubulin, and CP110. Dur-
ing the elongation of procentrioles, centrobin may function as a 
Figure 9.  Model of centrobin function during 
the  centriole  duplication  process.  The  model 
summarizes our finding on the function of cen-
trobin during centriole duplication. As the cell 
transitions from G1 to S phase, PLK4 activation 
leads to the recruitment of hSAS-6. Centrobin 
and other centriole initiation proteins are then 
recruited followed by centrobin, CPAP, CP110, 
-tubulin,  and  CEP135-mediated  elongation 
of the centriole. Centrobin is also required to 
maintain the stability of the newly assembled 
centrioles before their maturation. Centrobin is 
likely degraded or displaced from the original 
daughter centriole once the centriole duplica-
tion starts.723 Centrobin–tubulin binding in centriole duplication • Gudi et al.
beads followed by incubation with primary antibodies overnight at 4°C 
and then with protein G beads for 40 min at 4°C to precipitate the immuno-
complexes. After washing six times using lysis buffer, the bound proteins 
were fractionated on an SDS-PAGE gel, and Western blotting was per-
formed to detect the bound proteins. To test the dimerization potential of 
centrobin, transfected 293T cells were lysed using radioimmunoprecipita-
tion assay buffer containing 0.1% SDS. The rest of the protocol remained 
the same as described in this section, except that anti-myc antibody was 
used for the pull-down. For immunoprecipitations, 5 µg anti–-tubulin and 
5 µg anti-myc antibodies were used.
In vitro binding
GST-proteins were prepared by standard protocol using the BL21 strain of 
Escherichia coli and IPTG (Sigma-Aldrich) as the inducing agent. For the 
purification of GST-centrobin (1–903) and GST–-tubulin, 2 M urea was 
added to the lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 2 mM MgCl2, 
1% Triton X-100, 1% NP-40, and 100 mM PMSF). All the centrobin mutants 
were soluble and could be purified easily in the same buffer without urea. 
After induction, bacteria were pelleted and frozen overnight at 80°C, after 
which they were sonicated in lysis buffer. Glutathione beads (Pharmacia) 
were added to lysates to purify the proteins. Purified proteins were first 
quantified by Coomassie blue staining, after which equal amounts were 
used for in vitro binding with purified tubulins from HeLa cells (Cytoskele-
ton). In general, binding was performed for 2 h at 4°C to avoid polymer-
ization of the tubulin dimers.
Centriole duplication assay
HeLa and U2OS cells were either treated with 16 mM HU for 16 h (72 h 
after transfection) or pretreated with HU for 8 h, after which they were 
transfected with the indicated plasmids for 72 h. The transfected cells were 
immunostained with the indicated antibodies to visualize the centrioles. 
Data presented are a mean of the number of centrioles per cell from three 
independent experiments with 300 cells counted in every experiment or as 
otherwise mentioned. SEM has been calculated for the graphs.
CPAP-induced PLS assay
U2OS-CPAP  inducible  cells  were  transfected  with  control  or  centrobin 
siRNA for 72 h, after which 1 µg/ml doxycycline was used to induce the 
elongation of centrioles. Cells were harvested at different time points and 
processed for immunofluorescence. To assay the effect of centrobin-TuBD 
overexpression on the stability of PLSs, cells were first induced with doxy-
cycline for 96 h and then cotransfected with control or GFP–centrobin- 
TuBD together with dsRed–centrin 1–expressing vectors for 72 h. After 
staining with acetylated tubulin, 300 dsRed–centrin 1–positive cells in both 
control and mutant cells were analyzed for the presence of PLSs. The per-
centage of cells with PLSs was enumerated from three independent experi-
ments and presented.
EM
HeLa cells were pretreated with HU for 8 h and then transfected with con-
trol or centrobin-TuBD expression vectors for 72 h. The cells on coverslips 
were then fixed with 2% glutaraldehyde solution for 30 min followed by 
staining with osmium tetroxide and uranyl acetate and dehydration, after 
which the nuclei were then embedded in Epon 812 resin. 250-nm-thick 
sections were prepared on copper grids and evaluated using a transmis-
sion electron microscope (1230; JEOL).
Statistical analysis
SEM has been calculated and plotted for all the graphs. Asterisks on all 
histograms indicate that the differences are significant. The p-value was 
calculated between the control and test groups using the Student’s paired   
t test and was found to be P < 0.001.
Depletion efficiency of CPAP and CP110 RNAi
To assess the depletion efficiency of CPAP and CP110 RNAi, HeLa cells 
were grown on coverslips and transfected with control or CPAP or CP110 
RNAi for 48 h followed by treatment with HU for 16 h. For visualization of 
centrioles, cells grown on coverslips were left on ice for half an hour fol-
lowed by treatment with an extraction buffer (20 mM Hepes, pH 7.4,   
50 mM NaCl, 3 mM MgCl2, 300 mM sucrose, and 0.5% Triton X-100) and 
were fixed with ice-cold methanol at 20°C. The cells were then incubated 
with  appropriate  primary  antibodies  diluted  in  PBS  containing  0.02% 
Tween 20 and then incubated with Alexa Fluor 488/568/647–linked sec-
ondary antibodies followed by DAPI staining for 10 min. Coverslips were 
mounted onto slides in mounting media containing antifade reagent.
immunoprecipitation) and antiacetylated antibody (clone 6–11-B-1) were 
obtained from Sigma-Aldrich. Polyclonal anti-GFP antibody was obtained 
from Santa Cruz Biotechnology, Inc. Polyclonal anti–centrin 3 antibody 
was generated in the laboratory against full-length GST-tagged centrin 3 
and affinity purified. Polyclonal antibodies for CPAP, CP110, and hSAS-6 
were gifts from T.K. Tang (Institute of Biomedical Sciences, Taipei, Taiwan), 
B. Dynlacht (Department of Cell Biology, New York University, New York, 
NY), and P. Gönczy. T.K. Tang also provided us with polyclonal hSAS-6 
antibody. Monoclonal antibody against hSAS-6 was also purchased from 
Santa Cruz Biotechnology, Inc. Polyclonal antibody against CP110 was 
purchased from Bethyl Laboratories, Inc. Monoclonal anti–C-NAP1 anti-
body was purchased from BD. Purified HeLa cell tubulin for in vitro binding 
studies was obtained from Cytoskeleton. RNAi-mediated depletion of pro-
teins was performed using siRNA duplexes purchased from Thermo Fisher 
Scientific. The sequences for the siRNA against hSAS-6 were obtained 
from Leidel et al. (2005), and those for CPAP and CP110 were derived 
from Kleylein-Sohn et al. (2007), whereas the sequence for centrobin 
siRNA was obtained from Zou et al. (2005). Alexa Fluor 488/568/647–
linked secondary antibodies as well as -tubulin–Alexa Fluor 488 conju-
gate were purchased from Invitrogen.
Plasmid constructs
Cloning of centrobin (1–903) and centrobin-C (365–903) into GFP-N1 
and  pGEX  vectors  has  been  previously  described  (Zou  et  al.,  2005). 
pET28a centrobin (1–903) was generated by PCR using restriction en-
zymes EcoRI and NotI. Mutants of centrobin (1–364, 365–803, 365–703, 
365–603,  365–503,  465–903,  565–903,  665–903,  and  765–903) 
were generated by PCR using full-length centrobin as the template and 
were cloned into the pGEX vector using the restriction enzymes XhoI and SacII. 
The construct for expressing the GST–centrin 3 protein that was used to 
generate the polyclonal centrin 3 antibody was cloned by PCR using the 
enzyme sites BamHI and EcoRI.
Immunofluorescence
For visualization of centrioles, cells grown on coverslips were left on ice for 
half  an  hour  followed  by  treatment  with  an  extraction  buffer  (20  mM 
Hepes, pH 7.4, 50 mM NaCl, 3 mM MgCl2, 300 mM sucrose, and 0.5% 
Triton X-100) and fixed with ice-cold methanol at 20°C. The cells were 
then incubated with appropriate primary antibodies diluted in PBS contain-
ing 0.02% Tween 20 and then incubated with Alexa Fluor 488/568/647–
linked secondary antibodies followed by DAPI staining for 10 min. Coverslips 
were mounted onto slides in mounting media containing antifade reagent 
(Invitrogen) and imaged at room temperature. For the centriole elongation 
assay, U2OS-CPAP cells were induced by doxycycline for different time 
points in a 24-well plate. To visualize the centrioles, cells were placed on 
ice for half an hour to depolymerize the microtubules. The same staining 
procedure was followed as mentioned previously in this section. -Tubulin 
conjugated to Alexa Fluor 488 was used in the case of triple color staining. 
In the case of cells transfected with the centrobin-TuBD, cells were fixed 
with 4% PFA to avoid extraction of the mutated protein and then extracted 
with PBS buffer containing 0.5% Triton X-100 followed by blocking and 
staining with appropriate antibodies. In the aster-forming assay, cells were 
transfected with centrobin-TuBD for 72 h followed by nocodazole treatment 
for 2 h at 37°C. Subsequently, cells were washed extensively with PBS, 
and warm media were added to the cells for exactly 2 min, after which 
cells were fixed immediately with PFA and stained with -tubulin. To quan-
tify the PLS in U2OS-CPAP cells, dsRed–centrin 1 was cotransfected and 
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